1Kamstrup P R, Benn M, Hansen A T, et al. Extreme lipoprotein(a) and risk of myocardial infarction in the general population:The Copenhagen City Heart Study[J]. Circulation,2008,117:176-184.
2Virani S S, Brautbar A, Davis B C ,et al. Associations between lipoprotein (a) levels and cardiovascular outcomes in black and white subjects: The Atherosclerosis Risk in Communities (ARIC) study[J]. Circulation,2012,125:241-249.
7Minchos E D, Sibley C T, Baer J T,et al. Niacin and statin combi- nation therapy for atherosclerosis regression and prevention of cardiovascular disease events[J]. JACC,2012,59:2065-2067.
